Biblio

Export 3284 results:
Author Title Type [ Year(Asc)]
2024
A. Hambali, Jusril, N. Atiqah, Hashim, N. Fariesha M., Manan, N. Abd, Adam, S. Khadijah, Mehat, M. Zulfadli, Adenan, M. Ilham, Stanslas, J., and Hamid, H. Abdul, “The Standardized Extract of Centella asiatica and Its Fractions Exert Antioxidative and Anti-Neuroinflammatory Effects on Microglial Cells and Regulate the Nrf2/HO-1 Signaling Pathway.”, J Alzheimers Dis, vol. 99, no. s1, pp. S119-S138, 2024.
L. A. Digma, Winer, J. R., and Greicius, M. D., “Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.”, J Alzheimers Dis, vol. 97, no. 2, pp. 567-572, 2024.
L. Sannemann, Bartels, C., Brosseron, F., Buerger, K., Fliessbach, K., Freiesleben, S. Dawn, Frommann, I., Glanz, W., Heneka, M. T., Janowitz, D., Kilimann, I., Kleineidam, L., Lammerding, D., Laske, C., Munk, M. H. J., Perneczky, R., Peters, O., Priller, J., Rauchmann, B. - S., Rostamzadeh, A., Roy-Kluth, N., Schild, A. - K., Schneider, A., Schneider, L. - S., Spottke, A., Spruth, E. Jakob, Teipel, S., Wagner, M., Wiltfang, J., Wolfsgruber, S., Duezel, E., and Jessen, F., “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
S. Martínez-López, Tabone, M., Clemente-Velasco, S., González-Soltero, M. Del Rocío, Bailén, M., de Lucas, B., Bressa, C., Domínguez-Balmaseda, D., Marín-Muñoz, J., Antúnez, C., Gálvez, B. G., and Larrosa, M., “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
A. Rustamzadeh, Tafakhori, A., Ariaei, A., Heydari, M., Shah-Abadi, M. Ebrahimi, and Seif, F., “Targeting Caspases 3/6 and Cathepsins L/B May Decrease Laminopathy-Induced Apoptosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 211-221, 2024.
E. M. Sigurdsson, “Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.”, J Alzheimers Dis, vol. 101, no. s1, pp. S129-S140, 2024.
B. Irfan, Shammala, A. Abu, Alshaer, N., Nasser, E., Wajahath, M., Hamawy, A., Tahir, M., Khawaja, H., Khan, O., Fikry, K., Kaleem, A., Nasser, M., and Saleh, K. J., “There are dementia patients in Gaza too.”, J Alzheimers Dis, vol. 102, no. 2, pp. 317-320, 2024.
H. Takase, Hamanaka, G., Hoshino, T., Ohtomo, R., Guo, S., Mandeville, E. T., Lo, E. H., and Arai, K., “Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1421-1433, 2024.
M. O. Etekochay, Amaravadhi, A. Rao, González, G. Villarrubi, Atanasov, A. G., Matin, M., Mofatteh, M., Steinbusch, H. Wilhelm, Tesfaye, T., and Praticò, D., “Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 1, pp. 1-20, 2024.
C. L. Greenblatt and Lathe, R., “Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.”, J Alzheimers Dis, vol. 98, no. 2, pp. 343-360, 2024.
C. L. Greenblatt and Lathe, R., “Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.”, J Alzheimers Dis, vol. 98, no. 2, pp. 361-372, 2024.
A. Memon, Moore, J. A., Kang, C., Ismail, Z., and Forkert, N. D., “Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 2, pp. 623-637., 2024.
J. Rodrigo Do Santos, Catalão, C. Henrique R., Vulczak, A., Azzolini, A. Elisa Cale, and Alberici, L. Carla, “Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.”, J Alzheimers Dis, vol. 102, no. 2, pp. 424-436, 2024.
2023
J. Jia, Zhang, Y., Shi, Y., Yin, X., Wang, S., Li, Y., Zhao, T., Liu, W., Zhou, A., and Jia, L., “A 19-Year-Old Adolescent with Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 915-922, 2023.
J. Lilek, Ajroud, K., Feldman, A. Z., Krishnamachari, S., Ghourchian, S., Gefen, T., Spencer, C. L., Kawles, A., Mao, Q., Tranovich, J. F., Jack, C. R., Mesulam, M. - M., R Reichard, R., Zhang, H., Murray, M. E., Knopman, D., Dickson, D. W., Petersen, R. C., Smith, B., Ashe, K. H., Mielke, M. M., Nelson, K. M., and Flanagan, M. E., “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., “Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.”, J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
D. L. Alkon, Sun, M. - K., Tuchman, A. J., and Thompson, R. E., “Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.”, J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
J. - Y. Liu, Ma, L. - Z., Wang, J., Cui, X. - J., Sheng, Z. - H., Fu, Y., Li, M., Ou, Y. - N., Yu, J. - T., Tan, L., and Lian, Y., “Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1121-1132, 2023.
M. Lardelli, “An Alternative View of Familial Alzheimer's Disease Genetics.”, J Alzheimers Dis, vol. 96, no. 1, pp. 13-39, 2023.
C. Grobler, van Tongeren, M., Gettemans, J., Kell, D. B., and Pretorius, E., “Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development.”, J Alzheimers Dis, vol. 91, no. 1, pp. 43-70, 2023.
C. Milano, Hoxhaj, D., Del Chicca, M., Pascazio, A., Paoli, D., Tommasini, L., Vergallo, A., Pizzanelli, C., Tognoni, G., Nuti, A., Ceravolo, R., Siciliano, G., Hampel, H., and Baldacci, F., “Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.”, J Alzheimers Dis, vol. 94, no. 2, pp. 611-625, 2023.
R. H. Swerdlow, “The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview.”, J Alzheimers Dis, vol. 92, no. 3, pp. 751-768, 2023.
A. S. Buchman, Leurgans, S. E., Kim, N., Agrawal, S., Oveisgharan, S., Zammit, A. R., VanderHorst, V., Nag, S., and Bennett, D. A., “Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.”, J Alzheimers Dis, vol. 96, no. 2, pp. 563-578, 2023.
K. P. Kepp, Sensi, S. L., Johnsen, K. B., Barrio, J. R., Høilund-Carlsen, P. F., Neve, R. L., Alavi, A., Herrup, K., Perry, G., Robakis, N. K., Vissel, B., and Espay, A. J., “The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.”, J Alzheimers Dis, vol. 94, no. 2, pp. 497-507, 2023.
H. Salem, Suchting, R., Gonzales, M. M., Seshadri, S., and Teixeira, A. L., “Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.”, J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.

Pages